Lilly’s (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF Posted byZacks Equity Research September 10, 2021 Leave a comment on Lilly’s (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF The FDA bestows a Breakthrough Therapy status on Lilly’s (LLY) Jardiance for heart failure with preserved ejection fraction (HFpEF).